Digital microscopic imaging company Optiscan (ASX: OIL) has gotten feedback from the US Food and Drug Administration (FDA) in relation…
The commercialisation of osteoarthritis treatment ZILOSUL® has hit a hiccup in the United States with the US Food and Drug…